Compare Guardant Health Inc. Common Stock (GH) vs iShares Core S&P 500 ETF (IVV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Guardant Health Inc. Common Stock vs iShares Core S&P 500 ETF — how do they compare? Guardant Health Inc. Common Stock trades at $165.58 (market cap $22.22B), while iShares Core S&P 500 ETF trades at $780.81 (market cap $897.20B). The key difference: iShares Core S&P 500 ETF is far larger — about 40.4× Guardant Health Inc. Common Stock's market cap, and iShares Core S&P 500 ETF is trading nearer its 52-week high, Guardant Health Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and iShares Core S&P 500 ETF for 46 Days on average.
| GH | IVV | |
|---|---|---|
Market Cap | $22.22B | $897.20B |
Volume | 1,589,453 | 4,580,672 |
Sector | Health | Broad Market / Factor |
52-Week High | $187.22 | $782.58 |
52-Week Low | $61.73 | $634.93 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $22.86B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IVV, tracking the S&P 500, trades at $780.6, down 0.25% on the day. Technical indicators show a bullish trend with strong moving average support, though RSI suggests potential overbought conditions near-term. The ETF benefits from diversified exposure to large-cap US equities, with recent news highlighting strong corporate earnings growth expectations of 35% for 2026. Market sentiment remains mixed amid concerns about valuation and profit growth normalization.
Outlook remains cautiously optimistic given the S&P 500's historical bullish seasonal patterns and strong institutional support. Key risks include elevated Treasury yields, concentration in top holdings, and potential earnings growth deceleration to 15% in 2027. The ETF's low-cost structure and broad market exposure provide defensive characteristics during market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Guardant Health Inc. Common Stock
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →About iShares Core S&P 500 ETF
IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.
Read more on IVV →
